Healthcare Health/Fitness
Elan Shareholders Approve Buyback Plan
Elan shareholders approve buyback plan to avert takeover bid from Royalty Pharma. Shareholders of Irish drug maker, Elan, approved a US$1 billion or GBP651 million share buyback approval.
iRhythm Technologies Completes Series D Round of Funding
Led by Norwest Venture Partners, iRhythm Technologies latest funding round was able to raise US$16 million.
SBI Jefferies to Invest in Series B for Panviva Pty Ltd
Panviva Pty Ltd receives Aus$4 million from SBI Jefferies Asia Fund. Leading developer of software solutions for business processing guidance, Panviva Pty Ltd, announced that it was able to obtain equity financing worth Aus $4 Million in its Series B financing round from SBI Jefferies Asia Fund.
Cydan Launches Venture Backing for Drug De-Risking Accelerator
Cydan, through private equity placements, has unveiled its program of de-risking of drugs for therapeutic and commercial issues.